<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01005992</url>
  </required_header>
  <id_info>
    <org_study_id>CLCCQFQ-1</org_study_id>
    <nct_id>NCT01005992</nct_id>
  </id_info>
  <brief_title>Fractional Photothermolysis for the Treatment of Burn Scars</brief_title>
  <official_title>Fractional Photothermolysis for the Treatment of Burn Scars</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinica las Condes, Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Corporacion de ayuda al niño quemado (COANIQUEM)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Solta Medical</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinica las Condes, Chile</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of our study is to determine the effect of fractional photothermolysis laser in the
      treatment of burn scars.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the main problems in the management of burned patients is the treatment of post-burn
      scarring. Frequently this scars cover large areas, tend to retract, present pigmentary
      changes and are disfiguring, producing significant life quality impairment.

      Unfortunately, there are very few therapeutic options for treating these scars, which can be
      secondary to reconstructive surgery or after spontaneous healing. In the last decades most
      reports in scar treatment have included, pressure garments, chemical peeling, dermabrasion,
      ablative and non-ablative laser therapy and surgery with varying degrees of success. There is
      only one report treating burn scars with fractional laser, with good results.

      The aim of our study is to determine the effect of of a second-generation erbium-doped
      1,550-nm fractional photothermolysis laser (Fraxel SR laser, Reliant Technologies Inc.) in
      the treatment of burn scars.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <primary_completion_date type="Anticipated">April 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence of improvement in color and texture of burn scars, using digital colorimeter and digital photography.</measure>
    <time_frame>5 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse effects: pain, erythema, edema, hypopigmentation, hyperpigmentation, hypertrophic scar and keloid formation</measure>
    <time_frame>5 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in surface area and perimeter of burn scar</measure>
    <time_frame>5 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tissue pliability, elevation and flexibility with a digital piedemeter</measure>
    <time_frame>5 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in collagen fiber organization and blood vessel density with a reflectance laser confocal microscope.</measure>
    <time_frame>5 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Scar</condition>
  <arm_group>
    <arm_group_label>Laser treated scar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The standard treated scar arm consists of a similar lesion in an equivalent location in the same patient or the half of a lesion that is suitable to be divided (size at least 4% body surface area). This arm will be managed only with standard burn treatment modalities.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard scar management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The standard scar management arm consists of a similar lesion in an equivalent location in the same patient or the half of a lesion that is suitable to be divided (size at least 4% body surface area). This arm will be managed only with standard burn treatment modalities.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fractional laser treatment</intervention_name>
    <description>A complete treatment will consist in four laser sessions with a second-generation erbium-doped 1,550-nm fractional photothermolysis laser (Fraxel SR laser, Reliant Technologies Inc at 1-month intervals. Treatment will be delivered with a 15-mm tip and concomitant air-cooling system (Zimmer MedizinSystems, Irvine, CA). Fluence and treatment level will be registered on every session and will be adjusted according to patient tolerance.</description>
    <arm_group_label>Laser treated scar</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard scar management</intervention_name>
    <description>The standard treated scar arm consists of a similar lesion in an equivalent location in the same patient or the half of a lesion that is suitable to be divided (size at least 4% body surface area). This arm will be managed only with standard burn treatment modalities.</description>
    <arm_group_label>Standard scar management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Burn scars should be located on the anterior thorax or abdomen with at least 4 months
             of evolution.

          -  The scar should be slightly elevated, with erythema and with no signs of keloid
             formation.

          -  Maximum scar dimension: 0.2 - 1% body surface area.

          -  Acceptance of informed consent for laser treatment.

        Exclusion Criteria:

          -  Previous non-surgical treatment (i.e. dermabrasion, laser, peelings, bleaching agent.
             etc).

          -  Previous surgical treatment (i.e. graft)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rodrigo J Schwartz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinica Las Condes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rodrigo Schwartz, MD</last_name>
    <phone>56-2-6108661</phone>
    <email>schwartz.rodrigo@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinica Las Condes</name>
      <address>
        <city>Santiago</city>
        <state>RM</state>
        <country>Chile</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rodrigo J Schwartz, MD</last_name>
      <phone>56-2-6108661</phone>
    </contact>
    <contact_backup>
      <last_name>Fresia Solias</last_name>
      <email>investigacion@coaniquem.cl</email>
    </contact_backup>
    <investigator>
      <last_name>Rodrigo J Schwartz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fresia Solis</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gonzalo Eguiguren, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jorge Rojas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>pedro lobos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patricia Apt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <reference>
    <citation>Chrastil B, Glaich AS, Goldberg LH, Friedman PM. Second-generation 1,550-nm fractional photothermolysis for the treatment of acne scars. Dermatol Surg. 2008 Oct;34(10):1327-32. doi: 10.1111/j.1524-4725.2008.34284.x.</citation>
    <PMID>19040687</PMID>
  </reference>
  <reference>
    <citation>Glaich AS, Rahman Z, Goldberg LH, Friedman PM. Fractional resurfacing for the treatment of hypopigmented scars: a pilot study. Dermatol Surg. 2007 Mar;33(3):289-94; discussion 293-4.</citation>
    <PMID>17338685</PMID>
  </reference>
  <reference>
    <citation>Haedersdal M. Fractional ablative CO(2) laser resurfacing improves a thermal burn scar. J Eur Acad Dermatol Venereol. 2009 Nov;23(11):1340-1. doi: 10.1111/j.1468-3083.2009.03215.x. Epub 2009 Mar 4.</citation>
    <PMID>19309424</PMID>
  </reference>
  <reference>
    <citation>Haedersdal M, Moreau KE, Beyer DM, Nymann P, Alsbjørn B. Fractional nonablative 1540 nm laser resurfacing for thermal burn scars: a randomized controlled trial. Lasers Surg Med. 2009 Mar;41(3):189-95. doi: 10.1002/lsm.20756.</citation>
    <PMID>19291747</PMID>
  </reference>
  <reference>
    <citation>Waibel J, Beer K. Fractional laser resurfacing for thermal burns. J Drugs Dermatol. 2008 Jan;7(1):59-61.</citation>
    <PMID>18246699</PMID>
  </reference>
  <reference>
    <citation>Waibel J, Beer K. Ablative fractional laser resurfacing for the treatment of a third-degree burn. J Drugs Dermatol. 2009 Mar;8(3):294-7.</citation>
    <PMID>19271380</PMID>
  </reference>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 30, 2009</study_first_submitted>
  <study_first_submitted_qc>October 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2009</study_first_posted>
  <last_update_submitted>October 30, 2009</last_update_submitted>
  <last_update_submitted_qc>October 30, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Rodrigo Schwartz M.D.</name_title>
    <organization>Clinica Las Condes</organization>
  </responsible_party>
  <keyword>Scars secondary to injuries to tissues caused by contact with physical (heat, electricity) o chemical agent.</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

